Literature DB >> 23730351

Recommendations for preclinical research in hemorrhagic transformation.

Susan C Fagan1, Paul A Lapchak, David S Liebeskind, Tauheed Ishrat, Adviye Ergul.   

Abstract

Hemorrhagic transformation (HT) is an important complication of ischemic stroke and is responsible for most of the mortality associated with acute reperfusion therapy. Although many important publications address the preclinical models of ischemic stroke, there are no current recommendations on the conduct of research aimed at understanding the mechanisms and consequences of HT. The purpose of this review is to present the various models used in HT research, the clinical correlates, and the experimental variables known to influence the quantitation of HT in preclinical investigation. Lastly, recommendations for the conduct of preclinical research in HT are provided.

Entities:  

Keywords:  animal models; hemorrhagic infarction; hemorrhagic transformation; ischemic stroke; tissue plasminogen activator

Mesh:

Substances:

Year:  2013        PMID: 23730351      PMCID: PMC3667740          DOI: 10.1007/s12975-012-0222-5

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  56 in total

Review 1.  Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).

Authors:  A Eissa; I Krass; B V Bajorek
Journal:  J Clin Pharm Ther       Date:  2012-06-19       Impact factor: 2.512

2.  Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.

Authors:  L Zhang; Z G Zhang; R L Zhang; M Lu; J Adams; P J Elliott; M Chopp
Journal:  Stroke       Date:  2001-12-01       Impact factor: 7.914

3.  Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model.

Authors:  C H Chen; A Manaenko; Y Zhan; W W Liu; R P Ostrowki; J Tang; J H Zhang
Journal:  Neuroscience       Date:  2010-04-25       Impact factor: 3.590

4.  Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia.

Authors:  Zhiyong Qin; Murat Karabiyikoglu; Ya Hua; Robert Silbergleit; Yangdong He; Richard F Keep; Guohua Xi
Journal:  Stroke       Date:  2007-02-22       Impact factor: 7.914

5.  Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation.

Authors:  Gregory J del Zoppo; Harald Frankowski; Yu-Huan Gu; Takashi Osada; Masato Kanazawa; Richard Milner; Xiaoyun Wang; Naohisa Hosomi; Takuma Mabuchi; James A Koziol
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-22       Impact factor: 6.200

6.  Extension of the thrombolytic time window with minocycline in experimental stroke.

Authors:  Yoshihiro Murata; Anna Rosell; Robert H Scannevin; Kenneth J Rhodes; Xiaoying Wang; Eng H Lo
Journal:  Stroke       Date:  2008-10-16       Impact factor: 7.914

7.  Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats.

Authors:  Jean-Christophe Copin; Paolo Merlani; Taku Sugawara; Pak H Chan; Yvan Gasche
Journal:  Exp Neurol       Date:  2008-06-09       Impact factor: 5.330

8.  Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke.

Authors:  Anna Kozak; Adviye Ergul; Azza B El-Remessy; Maribeth H Johnson; Livia S Machado; Hazem F Elewa; Mohammed Abdelsaid; Daniel C Wiley; Susan C Fagan
Journal:  Stroke       Date:  2009-03-05       Impact factor: 7.914

9.  Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.

Authors:  Jean-Christophe Copin; Yvan Gasche
Journal:  Brain Res       Date:  2008-09-19       Impact factor: 3.252

10.  Mechanical reperfusion is associated with post-ischemic hemorrhage in rat brain.

Authors:  Aigang Lu; Joseph F Clark; Joseph P Broderick; Gail J Pyne-Geithman; Kenneth R Wagner; Pooja Khatri; Thomas Tomsick; Frank R Sharp
Journal:  Exp Neurol       Date:  2009-01-07       Impact factor: 5.330

View more
  15 in total

1.  A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-02-01       Impact factor: 6.829

2.  Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO--MMP-9 Pathway.

Authors:  Hansen Chen; Binghe Guan; Xi Chen; Xingmiao Chen; Caiming Li; Jinhua Qiu; Dan Yang; Ke Jian Liu; Suhua Qi; Jiangang Shen
Journal:  Transl Stroke Res       Date:  2017-12-23       Impact factor: 6.829

3.  Protective Effects of Autologous Bone Marrow Mononuclear Cells After Administering t-PA in an Embolic Stroke Model.

Authors:  Bing Yang; Weilang Li; Nikunj Satani; Duyen M Nghiem; XiaoPei Xi; Jaroslaw Aronowski; Sean I Savitz
Journal:  Transl Stroke Res       Date:  2017-08-23       Impact factor: 6.829

4.  Hyperbaric oxygen preconditioning attenuates hemorrhagic transformation through increasing PPARγ in hyperglycemic MCAO rats.

Authors:  Hetao Bian; Qin Hu; Xiping Liang; Di Chen; Bo Li; Jiping Tang; John H Zhang
Journal:  Exp Neurol       Date:  2014-12-24       Impact factor: 5.330

5.  Early Increased Bradykinin 1 Receptor Contributes to Hemorrhagic Transformation After Ischemic Stroke in Type 1 Diabetic Rats.

Authors:  Hongfei Sang; Zhongming Qiu; Jin Cai; Wenya Lan; Linjie Yu; Hao Zhang; Min Li; Yi Xie; Ruibing Guo; Ruidong Ye; Xinfeng Liu; Ling Liu; Renliang Zhang
Journal:  Transl Stroke Res       Date:  2017-07-19       Impact factor: 6.829

6.  Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2013-11-07       Impact factor: 6.829

Review 7.  Hemorrhagic transformation after ischemic stroke in animals and humans.

Authors:  Glen C Jickling; DaZhi Liu; Boryana Stamova; Bradley P Ander; Xinhua Zhan; Aigang Lu; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-27       Impact factor: 6.200

8.  Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.

Authors:  Sofiyan Saleem; Dong Wang; Tieqiang Zhao; Ryan D Sullivan; Guy L Reed
Journal:  Neuroscience       Date:  2021-01-17       Impact factor: 3.590

9.  Glycyrrhizin Prevents Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke with Delayed Thrombolysis Through Targeting Peroxynitrite-Mediated HMGB1 Signaling.

Authors:  Hansen Chen; Binghe Guan; Bin Wang; Haiwei Pu; Xiaoyu Bai; Xi Chen; Jihong Liu; Caiming Li; Jinhua Qiu; Dan Yang; Kejian Liu; Qi Wang; Suhua Qi; Jiangang Shen
Journal:  Transl Stroke Res       Date:  2019-12-24       Impact factor: 6.800

10.  Silencing VEGF-B Diminishes the Neuroprotective Effect of Candesartan Treatment After Experimental Focal Cerebral Ischemia.

Authors:  Tauheed Ishrat; Sahar Soliman; Wael Eldahshan; Bindu Pillai; Adviye Ergul; Susan C Fagan
Journal:  Neurochem Res       Date:  2018-08-07       Impact factor: 4.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.